116 related articles for article (PubMed ID: 1763196)
1. Emerging pharmacology of nerve growth factor.
Lapchak PA; Hefti F
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):851-60. PubMed ID: 1763196
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant human nerve growth factor on presynaptic cholinergic function in rat hippocampal slices following partial septohippocampal lesions: measures of [3H]acetylcholine synthesis, [3H]acetylcholine release and choline acetyltransferase activity.
Lapchak PA; Hefti F
Neuroscience; 1991; 42(3):639-49. PubMed ID: 1956513
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological stimulation reveals recombinant human nerve growth factor-induced increases of in vivo hippocampal cholinergic function measured in rats with partial fimbrial transections.
Lapchak PA; Jenden DJ; Hefti F
Neuroscience; 1992 Oct; 50(4):847-56. PubMed ID: 1448201
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hippocampal muscarinic receptor function by chronic nerve growth factor treatment in adult rats with fimbrial transections.
Lapchak PA; Araujo DM; Hefti F
Neuroscience; 1993 Mar; 53(2):379-94. PubMed ID: 8388084
[TBL] [Abstract][Full Text] [Related]
5. BDNF and NGF treatment in lesioned rats: effects on cholinergic function and weight gain.
Lapchak PA; Hefti F
Neuroreport; 1992 May; 3(5):405-8. PubMed ID: 1633277
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic intraventricular nerve growth factor treatment on vasoactive intestinal peptide and neuropeptide Y levels in the hippocampal formation and cerebral cortex following fimbrial transections.
Lapchak PA; Araujo DM
Brain Res; 1994 Aug; 654(1):1-7. PubMed ID: 7982082
[TBL] [Abstract][Full Text] [Related]
7. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions.
Hefti F; Dravid A; Hartikka J
Brain Res; 1984 Feb; 293(2):305-11. PubMed ID: 6697222
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic nerve growth factor treatment on hippocampal [3H]cytisine/nicotinic binding sites and presynaptic nicotinic receptor function following fimbrial transections.
Lapchak PA; Araujo DM; Hefti F
Neuroscience; 1994 May; 60(2):293-8. PubMed ID: 8072684
[TBL] [Abstract][Full Text] [Related]
9. Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration.
Venero JL; Knüsel B; Beck KD; Hefti F
Neuroscience; 1994 Apr; 59(4):797-815. PubMed ID: 8058122
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic basic fibroblast growth factor administration to rats with partial fimbrial transections on presynaptic cholinergic parameters and muscarinic receptors in the hippocampus: comparison with nerve growth factor.
Araujo DM; Lapchak PA; Hefti F
J Neurochem; 1993 Sep; 61(3):899-910. PubMed ID: 8360689
[TBL] [Abstract][Full Text] [Related]
11. GM1 ganglioside enhances cholinergic parameters in the brain of senescent rats.
Hadjiconstantinou M; Karadsheh NS; Rattan AK; Tejwani GA; Fitkin JG; Neff NH
Neuroscience; 1992; 46(3):681-6. PubMed ID: 1545916
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of nerve growth factor-induced alterations in cholinergic fibre length and presynaptic terminal size in cortex of lesioned rats by the monosialoganglioside GM1.
Garofalo L; Ribeiro-da-Silva A; Cuello AC
Neuroscience; 1993 Nov; 57(1):21-40. PubMed ID: 8278055
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor affects uninjured, adult rat septohippocampal cholinergic neurons.
Fusco M; Oderfeld-Nowak B; Vantini G; Schiavo N; Gradkowska M; Zaremba M; Leon A
Neuroscience; 1989; 33(1):47-52. PubMed ID: 2601860
[TBL] [Abstract][Full Text] [Related]
14. Two different molecules, NGF and free-HCNP, stimulate cholinergic activity in septal nuclei in vitro in a different manner.
Ojika K; Mitake S; Kamiya T; Kosuge N; Taiji M
Brain Res Dev Brain Res; 1994 May; 79(1):1-9. PubMed ID: 8070052
[TBL] [Abstract][Full Text] [Related]
15. Effect of nerve growth factor on the lesioned septohippocampal cholinergic system of aged rats.
Yunshao H; Zhibin Y; Yici C
Brain Res; 1991 Jun; 552(1):159-63. PubMed ID: 1655166
[TBL] [Abstract][Full Text] [Related]
16. Long-term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway.
Junard EO; Montero CN; Hefti F
Exp Neurol; 1990 Oct; 110(1):25-38. PubMed ID: 2170164
[TBL] [Abstract][Full Text] [Related]
17. Interaction between impulse-flow and delta 9-tetrahydrocannabinol within the septal-hippocampal cholinergic pathway of rat brain.
Lindamood C; Colasanti BK
J Pharmacol Exp Ther; 1981 Nov; 219(2):580-4. PubMed ID: 6270316
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat.
Koliatsos VE; Applegate MD; Knüsel B; Junard EO; Burton LE; Mobley WC; Hefti FF; Price DL
Exp Neurol; 1991 May; 112(2):161-73. PubMed ID: 2037030
[TBL] [Abstract][Full Text] [Related]
19. Use of a digital brain atlas to compare the distribution of NGF- and bFGF-protected cholinergic neurons.
Schwaber JS; Due BR; Rogers WT; Junard EO; Sharma A; Hefti F
J Comp Neurol; 1991 Jul; 309(1):27-39. PubMed ID: 1654343
[TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor induces a dose-dependent and long-lasting increase of choline acetyltransferase activity in the septal area and hippocampus of uninjured rats.
Vantini G; Fusco M; Schiavo N; Gradkowska M; Zaremba M; Leon A; Oderfeld-Nowak B
Acta Neurobiol Exp (Wars); 1990; 50(4-5):323-31. PubMed ID: 2130652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
